ChiCTR2400085363 版本V1.0 版本创建时间2024/06/05 23:56:35 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400085363 

最近更新日期:

Date of Last Refreshed on:

2024-06-05 23:56:22 

注册时间:

Date of Registration:

2024-06-05 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

耳穴埋豆联合中医情志护理及五音疗法对眼科患者围术期睡眠质量的影响

Public title:

The effect of ear point embedding beans combined with traditional Chinese medicine emotional nursing and five tone therapy on the perioperative sleep quality of ophthalmic patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

耳穴埋豆联合中医情志护理及五音疗法对眼科患者围术期睡眠质量的影响

Scientific title:

The effect of ear point embedding beans combined with traditional Chinese medicine emotional nursing and five tone therapy on the perioperative sleep quality of ophthalmic patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

陈皑皑 

研究负责人:

陈皑皑 

Applicant:

Aiai Chen 

Study leader:

CHEN AIAI 

申请注册联系人电话:

Applicant telephone:

+86 130 5675 3002

研究负责人电话:

Study leader's telephone:

+86 130 5675 3002

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

841633226@qq.com

研究负责人电子邮件:

Study leader's E-mail:

841633226@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

浙江省宁波市鄞州区北明程路599号

研究负责人通讯地址:

北明程路599号

Applicant address:

599 Beimingcheng Road, Yinzhou District, Ningbo City, Zhejiang Province

Study leader's address:

599 beimingcheng Road

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

宁波市眼科医院

Applicant's institution:

Ningbo Eye Hospital

研究负责人所在单位:

宁波市眼科医院

Affiliation of the Leader:

Ningbo Eye Hospital

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

甬眼医伦审2024研第007号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

宁波市眼科医院伦理委员会

Name of the ethic committee:

Ethics Committee of Ningbo Eye Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2024-04-03 00:00:00

伦理委员会联系人:

郑双双

Contact Name of the ethic committee:

Zheng ShuangShuang

伦理委员会联系地址:

北明程路599号

Contact Address of the ethic committee:

599 beimingcheng Road

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 574 8786 2233

伦理委员会联系人邮箱:

Contact email of the ethic committee:

752740695@qq.com

研究实施负责(组长)单位:

宁波市眼科医院

Primary sponsor:

Ningbo Eye Hospital

研究实施负责(组长)单位地址:

北明程路599号

Primary sponsor's address:

599 beimingcheng Road

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

浙江

市(区县):

Country:

China

Province:

Zhejiang

City:

单位(医院):

宁波市眼科医院

具体地址:

北明程路599号

Institution
hospital:

Ningbo Eye Hospital

Address:

599 beimingcheng Road

经费或物资来源:

2024年度宁波市眼科医院院级第一批科技计划

Source(s) of funding:

The first batch of hospital level science and technology plans for Ningbo Ophthalmology Hospital

Target disease:

Postoperative ophthalmic patients

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

探讨耳穴埋豆联合中医情志护理及五音疗法对眼科患者围术期睡眠质量的影响。方法60例眼科患者随机分为两组各30例,对照组采用常规护理,观察组采用耳穴埋豆联合中医情志护理及五音疗法,比较两组的负性情绪及睡眠质量。  

Objectives of Study:

Exploring the effect of ear point embedding with beans combined with traditional Chinese medicine emotional care and five tone therapy on the perioperative sleep quality of ophthalmic patients. Method: Sixty ophthalmic patients were randomly divided into two groups, with 30 cases in each group. The control group received routine nursing care, while the observation group received ear acupoint bean embedding combined with traditional Chinese medicine emotional care and five tone therapy. The negative emotions and sleep quality of the two groups were compared.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.①进行眼科手术治疗。
2.②实验室检查指标正常。

Inclusion criteria

1.①Performing ophthalmic surgery for treatment.
2.②Normal laboratory test indicators.

排除标准:

1.①既往存在失眠症状者。
2.②患有精神系统或心理障碍性疾病者。
3.③严重肝肾功能不全者。
4.④存在凝血功能障碍者。
5.⑤耳部皮肤破溃不能进行耳穴压豆者。
6.⑥存在听力障碍者。

Exclusion criteria:

1.①Individuals with previous insomnia symptoms;
2.②Individuals with mental or psychological disorders;
3.③Severe liver and kidney dysfunction;
4.④Individuals with coagulation dysfunction;
5.⑤Patients with ear skin rupture and inability to perform ear acupressure;
6.⑥Individuals with hearing impairments;

研究实施时间:

Study execute time:

From 2024-01-01 00:00:00 To 2025-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-06-05 00:00:00 To 2025-12-31 00:00:00  

干预措施:

Interventions:

组别:

对照组

样本量:

30

Group:

control group

Sample size:

干预措施:

常规护理

干预措施代码:

Intervention:

Routine care

Intervention code:

组别:

干预组

样本量:

30

Group:

Intervention group

Sample size:

干预措施:

中医术后护理

干预措施代码:

Intervention:

Postoperative care in traditional Chinese medicine

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

浙江 

市(区县):

 

Country:

China 

Province:

Zhejiang 

City:

 

单位(医院):

宁波市眼科医院 

单位级别:

三级甲等 

Institution
hospital:

Ningbo Eye Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

焦虑、抑郁自评量表(SAS,SDS)

指标类型:

主要指标

Outcome:

Self Rating Anxiety and Depression Scale (SAS, SDS)

Type:

Primary indicator

测量时间点:

术后第一天

测量方法:

问卷调查

Measure time point of outcome:

On the first day after surgery

Measure method:

questionnaire survey

指标中文名:

睡眠质量健康指数(PSQI)

指标类型:

主要指标

Outcome:

Pittsburgh Sleep Quality Index (PSQI)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

患者满意度

指标类型:

次要指标

Outcome:

Patient satisfaction

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 90 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数表法

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number table method

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

开放标签,对评估者隐藏分组

Blinding:

Open-label study with blinded-evaluators

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

none

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

问卷调查

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

questionnaire survey

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2024-06-05 23:56:22